Arabic Arabic English English French French German German
dark

Cytokine APRIL protects from atherosclerotic cardiovascular disease

Heart attacks and strokes are the main causes of death and loss of productive years globally. These clinical complications are caused by atherosclerosis, which is a chronic disease that leads to the accumulation of LDL cholesterol and immune cells in the inner layer of arteries and thereby resulting in the build-up of atherosclerotic plaques. Researchers from the Department of Laboratory Medicine of the Medical University of Vienna in collaboration with colleagues from the University of Lausanne (Switzerland) and the University of Cambridge (UK) have identified that a cytokine called A Proliferation Inducing Ligand (APRIL) plays a major protective role against the formation of atherosclerotic plaques. The study was now published in the prestigious journal Nature. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Learning patients’ life stories leads to improved health outcomes

Next Post

Smart Choice reports breakthrough growth, key hires

Related Posts
Total
0
Share